ABSTRACT
Background The relationship between anxiety and depressive symptoms is complex and may vary across the lifespan. Symptom network analyses offer a powerful tool to examine these interactions, but few studies have directly compared symptom networks in younger and older adults.
Methods We analysed data from the Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study, including 786 participants aged 18 to 88, who reported at least subclinical levels of symptoms on the Hospital Anxiety and Depression Scale (HADS). Network analysis was employed to examine symptom communities, within- and between-community connectivity, and centrality measures across age groups.
Results The overall network structure, largely separating anxiety and depressive symptoms into two communities, remained stable across age groups. However, in older adults, there was a reduction in connectivity within the depression community, and a reduction in between-community connectivity for both the depression and anxiety communities. Moreover, while “panic” emerged as a consistently central symptom across both age groups, “rumination” and “restlessness” were the key bridge symptoms in young and older adults, respectively.
Discussion Our findings reveal both stable and dynamic aspects of depression and anxiety symptoms across the lifespan. Reduced within-community connectivity for depressive symptoms suggests greater heterogeneity in how depression manifests in older populations. The shift in bridging symptoms, from cognitive (rumination) in young adults to somatic (restlessness) in older adults, suggests subtle yet clinically important differences in how depression and anxiety are linked across the lifespan. Our results underscore the need for tailored, age-dependent treatment in depression and anxiety.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Cam-CAN research was supported by the Biotechnology and Biological Sciences Research Council (BB/H008217/1). NW was supported by an Israel Science Foundation Personal Research Grant (1603/22). We are grateful to the Cam-CAN respondents and their primary care teams in Cambridge for their participation in this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We analysed data from the Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study. Ethical approval was granted by the local ethics committee, Cambridgeshire 2 (now East of England – Cambridge Central) Research Ethics Committee (reference: 10/H0308/50).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
